Complex communities of bacteria, fungi, and viruses thrive on our skin. The composition of these communities depends on skin characteristics, such as sebaceous gland concentration, moisture content, and temperature, as well as on host genetics and exogenous environmental factors. Recent metagenomic studies have uncovered a surprising diversity within these ecosystems and have fostered a new view of commensal organisms as playing a much larger role in immune modulation and epithelial health than previously expected. Understanding microbe-host interactions and discovering the factors that drive microbial colonization will help us understand the pathogenesis of skin diseases and develop new promicrobial and antimicrobial therapeutics. ( J Am Acad Dermatol 2013;69:143-55.) 
B
eginning with van Leeuwenhoek's invention of the microscope in the 17th century, studies have linked microbes to human disease by uncovering direct, one-to-one relationships between pathogens and skin pathologies. Seminal discoveries include human papillomavirus as a cause of squamous cell cancer and Treponema pallidum as the cause of syphilis. More recently, metagenomic advances have allowed us to examine not just one pathogen at a time but thousands of different microbes simultaneously. With these techniques, scientists have uncovered surprisingly diverse and complex microbial communities thriving on the epithelial surfaces of every individual. These communities influence human physiology, immunity, and disease in ways that we are now just beginning to appreciate.
An estimated 1 million bacteria, with hundreds of distinct species, inhabit each square centimeter of skin. 1 Many studies have suggested that microbes may contribute even to noninfectious pathologies, such as atopic dermatitis (AD), psoriasis, rosacea, and acne although recent molecular studies are beginning to explain the complex relationship between host and microorganism. [2] [3] [4] [5] [6] These studies have established a new paradigm for how microbes cause disease, where not just pathogens but also imbalances in the commensal ecosystem cause skin pathology. Whether this imbalance is primary or secondarily caused by changes in host skin and immunity and how this imbalance potentiates epithelial dysfunction, immune dysregulation, or overgrowth of pathogenic microbes are new questions on the research frontier that will impact how we understand and treat skin diseases. Recent reviews have comprehensively summarized the work to date on the skin microbiome. [7] [8] [9] [10] This review will briefly describe representative studies of the skin microbiome but will focus primarily on the current gaps in research, relevant clinical questions, and potential methods for addressing these questions. 
WHAT IS METAGENOMICS?
Historically, characterizing cutaneous microbes involved culturing skin swabs or biopsy specimens. However, less than 1% of bacterial species can be cultivated with standard laboratory conditions, and many that do grow are outcompeted by fastergrowing organisms. 11 Consequently, easily cultivated bacteria or fungi, such as Staphylococcus or Malassezia species, were overrepresented in early microbial surveys. Recent advances in DNA amplification and sequencing technology can now bypass the culture steps and allow for more complete, unbiased views of skin microbiota and their genetic content, collectively called the ''microbiome'' (for glossary, see Table I at http://www.jaad.org).
The culture-free, sequencebased method of analyzing any collection of microorganisms, such as skin microbiota, can be referred to as ''metagenomics. '' 12 In analyzing bacterial microbiomes, this method most often involves amplifying the prokaryotic small subunit ribosomal RNA (16S rRNA) gene by polymerase chain reaction (PCR) directly from skin samples (Fig 1, A) . 13, 14 The 16S rRNA gene exists in all bacteria and archaea but not in eukaryotes. It contains both conserved regions that serve as binding sites PCR primers and variable regions for taxonomic classification after high-throughput sequencing of the PCR products (Fig 1, B) . 15, 16 Sequences that are more than 97% identical can often be classified within 1 species. Within 1 species, sequence variations are assumed to be a result of intraspecies strain variations. Also, the number of sequences counted within 1 species represents the relative abundance of that species in the original skin sample. Thus, this metagenomic approach gives a comprehensive picture of the bacterial community by providing both identification and relative abundances of all present species (Fig 2) .
THE NORMAL MICROBIOME ON HUMAN SKIN
In 2007, the National Institutes of Health launched the Human Microbiome Project to survey microbial content across 242 healthy adults, develop a reference catalog of microbial genome sequences, and understand how specific habitats in the gut, genitourinary system, and skin contribute to health and disease states. 14, [17] [18] [19] Recently, results from the Human Microbiome Project were published that describe their metagenomic methods and the publicly available databases of whole genome and 16S rRNA gene sequences. 18 This work and other studies in the past decade have characterized the skin microbiome of healthy volunteers and its variation across different spatial niches, individuals, and time (Table II ; available at http:// www.jaad.org).
In utero, fetal skin is sterile, but minutes after birth, colonization begins to occur. [20] [21] [22] Newborns are first homogenously colonized with a similar, low-diversity microbiome over all skin sites. 20, 22 As infants contact environmental microbiota and as different areas of the skin develop distinct moisture, temperature, and glandular characteristics, individual skin habitats arise with divergent, increasingly diverse microbiota. 22 These habitats then continue to transform with puberty, aging, and environmental exposures. [23] [24] [25] [26] [27] Metagenomic studies using 16S rRNA sequencing in adults show that the vast majority of skin bacteria and gut flora fall into 4 phyla: Actinobacteria, Firmicutes, Bacteroidetes, and Proteobacteria, but within these phyla exist thousands of distinct species. 1, 26, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] A survey of the palm microbiome, for instance, found 4742 distinct species in 51 healthy subjects, with an average of 158 species coexisting on a single palm. 26 Surveys of microbiomes over 20 different skin sites show that similar habitats, such as the axillae and the popliteal fossae, have similar microbial compositions (Fig 3) . 31, 38 For instance, in all individuals, Propionibacterium species dominate sebaceous areas such as the forehead, retroauricular crease, and back, whereas Staphylococcus and Corynebacterium species dominate moist areas, such as the axillae (Fig 3) . Surprisingly, abundant Gram-negative organisms, previously thought to colonize the skin rarely as gastrointestinal contaminants, were found in the microbiomes of dry skin habitats, such as the forearm or leg.
In addition to differing species compositions, each habitat also has its own characteristic level of microbial diversity and temporal fluctuation. For
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Recent metagenomic studies have revealed that diverse and complex microbial ecosystems inhabit the skin, collectively known as the skin microbiome. This review summarizes recent studies characterizing the skin microbiome and highlights current gaps in research. Understanding how the skin microbiome interacts with the host immune system and with pathogens could pave the way to new antimicrobial and promicrobial therapeutics for a wide array of diseases, including atopic dermatitis, psoriasis, chronic wounds, and cancer.
example, antecubital fossae had the highest variance in species composition between subjects, called beta diversity, but each single antecubital fossa had less alpha diversity, or fewer distinct species within 1 habitat when compared with other sites. 19 Different skin sites also have different levels of temporal variability. Partially occluded sites, such as the inguinal crease, had Metagenomics is culture-free method to assess skin microbiota. A, DNA is purified directly from skin swab or biopsy specimen. This DNA contains a mixture of genomic DNA from skin and microbial cells. Polymerase chain reaction (PCR) with primers that anneal to the conserved region of the 16S ribosomal RNA (rRNA) gene is used to amplify bacterial DNA. Then, these PCR amplicons are sequenced. Finally, sequences can be classified taxonomically to give species identities within the microbiome and sequences can be counted to give relative abundances of each species. B, Alignment of 16S rRNA gene sequences between Staphylococcus aureus and Staphylococcus epidermidis downloaded from the National Center for Biotechnology Information and aligned via Geneious (http://www.geneious.com/). Blue lines show nucleotides that differ between 2 species. Inset shows example of specific sequence differences.
J AM ACAD DERMATOL VOLUME 69, NUMBER 1 more stable bacterial communities over time, 31 whereas dryer and more exposed skin sites, such as the palm, had higher diversity and more temporal fluctuation. 38 Characterization of skin habitats by indices such as alpha diversity, beta diversity, and temporal volatility provides information about community structure and can be a quantitative method to follow changes in the skin microbiome after antibiotics, pathogen arrival, and other perturbations.
Consistent with the idea of ecological niches, transplanting microbes from one habitat to another, such as from the tongue to the forehead, caused only a transient presence of tongue microbiota on the forehead with eventual return to a forehead microbiome. 38 Individual genetics and environmental exposures also contribute to microbiome composition, as contralateral habitats within an individual are more similar than the same habitat across different individuals. 1, 31, 38 In addition, within one species of . Number of sequences in metagenome that correspond to each phylogenetic category is listed. For example, 3790 sequences making up 62% of metagenome's sequences were found to be Actinobacteria by similarity to references sequences. B, Pie chart showing microbial composition within same example metagenome. Chart was generated using the Krona software available on MG-RAST (http:// metagenomics.anl.gov/). bacteria, strain-level genotypic differences exist in subsets of the populations, potentially correlating to the genetic or immune characteristics of host individuals. 19 Although metagenomics studies using 16S rRNA gene sequencing have revolutionized our understanding of the healthy skin microbiome, many questions need to be addressed. A recent study showed that the nares, antecubital fossa, volar forearm, and popliteal fossa of children differ globally from the same sites in adults in terms of bacterial composition 39 (Table II ; available at http://www. jaad.org). For example, Staphylococcus aureus was more abundant in the nares of children, and this was significantly correlated to Staphylococcus aureus colonization at other skin sites. 39 Continued investigation of skin microbiome composition in a variety of age and ethnic groups may help elucidate why certain populations are more susceptible to certain pathologies and what host or environmental factors determine the composition of skin ecosystems.
In addition to the abundant Propionibacterium, Staphylococcus, and Corynebacterium species, most species in the skin microbiome each make up less than 1% of the total flora in any particular habitat. These minority species are not well studied and many were not previously known to colonize the skin, but low-abundance species could nonetheless be linchpins of the skin ecosystem. Metagenomic studies of soil ecosystems have shown that several low-abundance fungal species are actually highly active in essential decomposition processes. 40 Therefore, it is possible that low-abundance skin microbes also exert large influences over abundant species, such as Staphylococcus epidermidis, or pathogenic species, such as Staphylococcus aureus. One way to detect relationships between pairs of species in a microbiome is to use maximal information-based nonparametric exploration statistics. This statistical tool was recently developed and has been applied to a variety of large data sets, including the gut microbiome. 41 Application of J AM ACAD DERMATOL VOLUME 69, NUMBER 1 maximal information-based nonparametric exploration to skin microbiome data could hint at which pairs of bacterial species are functionally symbiotic or antagonistic and how disruptions in a few species could change the ecosystem as a whole. Another method to study low-abundance species in the skin microbiome is metatranscriptomics, which has been used to study soil microbiomes. 40, 42 All published studies surveying skin microbiomes have used a DNA-centered, genomic approach. By contrast, in metatranscriptomics, RNA, not DNA, is purified from a skin sample before sequencing. Because the cell itself has already amplified the RNA, this approach can better detect lowabundance organisms. In addition, transcriptome data capture metabolic activity and can reveal whether a low-abundance species contributes proportionally more to the ecosystem. Furthermore, because RNA is much less stable than DNA, the metatranscriptome would only identify microorganisms that are alive, providing a more accurate snapshot in time than metagenomics. However, one technical challenge to this approach is the limitation on skin specimen size compared with a soil sample, which makes isolating enough RNA more difficult. Therefore, this metatranscriptomics approach may be more applicable when single-molecule DNA sequencing can be performed in a more inexpensive and high-throughput manner.
THE MICROBIOME IN AD
One frequently studied disease using metagenomics is AD. Although AD is noninfectious, flareups may relate to changes in cutaneous microbes. AD is a chronic, relapsing disorder that affects approximately 15% of children in the United States. Many hypotheses have been invoked for the pathogenesis of AD, including a deficiency in the epithelial barrier protein filaggrin, colonization by Staphylococcus aureus, and immune hypersensitivity. [43] [44] [45] [46] [47] Empirically effective treatments for AD include antibiotics, steroids, and dilute bleach baths. 48 These are thought to work by decreasing bacterial load and inhibiting a dysfunctional, exuberant immune response to skin flora.
Using culture methods, Staphylococcus aureus colonization and infection have been commonly associated with AD. 49 Consistent with this, a metagenomic study showed that Staphylococcus species increased from 35% to 90% of the microbiome during flareups, but surprisingly, both Staphylococcus aureus and Staphylococcus epidermidis increased. 50 Thus, microbiome data suggest that understanding how Staphylococcus aureus affects AD will require understanding Staphylococcus aureus fluctuations as part of a larger, complex ecosystem. Staphylococcus epidermidis can produce molecules that selectively inhibit Staphylococcus aureus, 51 arguing that Staphylococcus epidermidis may be antagonistic to Staphylococcus aureus. However, in the gut, pathogenic species can more easily colonize when closely related commensal species are also abundant, 52 suggesting 50 Future research should examine whether a change in host skin first triggers changes in species composition, thus allowing for Staphylococcus overgrowth, or if Staphylococcus overgrowth is a primary event that then forces other species to change in abundance.
These questions might be further investigated in mouse models of AD, such as the NC/Nga mouse, which develops disease that is clinically and histologically similar to AD after exposure to environmental aeroallergens. 53, 54 Importantly, understanding how Staphylococcus aureus relates to microbiome fluctuations as a whole may reveal novel treatments of AD flareups such as rebalancing and rediversifying the skin microbiome rather than eliminating Staphylococcus aureus or bacterial burden on the skin. Lessons learned from AD might also inform our understanding of other skin pathologies, such as psoriasis, acne, and chronic wounds, which may also be related to microbiome imbalances.
Microbiome studies similar to those in AD have been performed in patients with psoriasis, 5, 55, 56 chronic wounds, [57] [58] [59] or acne 60 (Table II ; available at http://www.jaad.org). In chronic wounds, the microbiome was found to be less diverse than that of healthy skin but no consensus microbiome was found, even among wounds of the same etiology. [57] [58] [59] 61 In contrast, the follicular microbiome in acne was more diverse than that of healthy follicles, which are colonized almost exclusively by Propionibacterium acnes. 60 And in psoriasis, there is a lack of consensus in how and if the microbiome of psoriatic plaques differs from that of normalappearing skin. 5, 55, 56 Metagenomic studies with more detailed stratification based on patients' clinical status and treatment regimens may help elucidate the clinical significance of these findings.
ANTIBIOTICS AND THE MICROBIOME
A major gap in our current understanding is how current therapies affect the microbiome. Many dermatologic treatments are bactericidal or immunosuppressive and may have unexpected effects on the microbiome. In the gut, antibiotics were found to cause not only a transient loss in bacterial diversity but also a long-term loss of microbiome members beyond the direct antibiotic targets. [62] [63] [64] Even though vancomycin targets only Gram-positive bacteria, Gram-negative populations were depleted after vancomycin treatment. 64 This effect on off-target microbes likely occurs as a result of indirect relationships between bacterial species that are forged through ecosystem-wide processes, such as metabolite exchange and waste product removal. 65 Furthermore, after cessation of antibiotic treatment and even after restoration of bacterial density in the gut, the long-term changes in microbial community composition facilitate colonization by pathogens, such as vancomycin-resistant Enterococcus, which then potentiates bloodstream invasion. 66 Therefore, using bactericidal treatments such as antibiotics in AD or ultraviolet light in psoriasis may have wide-reaching, unknown effects on the microbiome and disease recurrence. Currently, the data on probiotic treatments for skin diseases such as AD remain controversial. A meta-analysis of 7 Cochrane and non-Cochrane reviews showed no clear evidence that interventions such as probiotics, maternal antigen avoidance, and different antigenavoidance diets reduced the incidence of AD. 67 Although pooled data showed a reduction in eczema incidence with exclusive breast-feeding for at least 6 months and with maternal probiotic supplementation, these data were based on small trials. 67 In addition, these trials focused on modulating the gut microbiome to affect skin health. Future investigation into treatments for microbe-related skin pathologies could be directed toward probiotic regimens that directly modulate the skin microbiome.
METAGENOMICS TO INVESTIGATE CUTANEOUS INFECTIONS
Metagenomic studies have provided insights into AD, psoriasis, acne, and chronic wounds. These diseases are noninfectious but can be influenced by shifts and imbalances in skin microbiota. Organisms that cause cutaneous infections can also be studied via metagenomics, which could be particularly useful in those infections associated with a wide range of clinical features and wide geographic and host variability. One such organism is Staphylococcus aureus, a major source of hospital-and community-acquired infections. Its manifestations range from asymptomatic nasal carriage to impetigo, enterotoxin-mediated desquamation, severe necrotizing pneumonia, and septicemia. In addition to a wide range of virulence and toxin-producing capabilities, Staphylococcus aureus also exhibits variable antibiotic susceptibility, including methicillin and vancomycin resistance. Its widespread pathogenicity and increasing antibiotic resistance coupled with declining treatment options makes Staphylococcus aureus an important pathogen to study from a patient safety and public health perspective. [68] [69] [70] [71] Thus far, 14 strains of Staphylococcus aureus have been fully sequenced, with many more partially sequenced. [72] [73] [74] [75] [76] [77] In addition, DNA microarrays have been developed for genome comparisons between strains of Staphylococcus aureus. [78] [79] [80] [81] [82] Studies using whole genome sequencing and DNA microarrays show that virulence and antibiotic resistance are associated with both host-specific and lineage-specific factors 72, 80, 83 and are encoded in many different ways, including point mutations or small inserts in certain genes, large mobile genetic elements composed of many virulence genes that travel together, 78, 84, 85 and conjugative plasmids from unrelated species, such as vancomycin-resistant Enterococcus.
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The study of vancomycin-resistant Staphylococcus aureus (VRSA) provides an example of how genomic studies can characterize the emergence and epidemiology of antibiotic-resistant strains to identify future therapeutic targets. Since its emergence, all VRSA isolates have been found to be strains within the Clonal Complex 5 (CC5) lineage and resistance seems to arise from acquisition of a transposon, designated Tn1546, from vancomycin-resistant Enterococcus during the course of each infection rather than spread of VRSA between individuals. [86] [87] [88] [89] Recently, a comparative study of 12 whole VRSA genomes revealed that CC5 strains have several genetic features not present in other Staphylococcus aureus lineages, which could promote acquisition of plasmids from other bacterial species while also impairing host immune function. 90 In addition to techniques using whole genomes, methods such as multilocus sequence typing 91 and spa typing 92, 93 have been developed to analyze Staphylococcus aureus epidemiology across hundreds of samples that differ in clinical, geographic, or host characteristics. Similar to the 16S rRNA metagenomic method described earlier, multilocus sequence typing and spa typing rely on culture-free sample collection, then sequencing of specific regions that exist in all Staphylococcus aureus strains, and finally classification of strains based on strainspecific alleles. Studies using these approaches have shown that although a large number of Staphylococcus aureus lineages are present worldwide, only 10 predominate and among these, 3 lineages are rarely associated with methicillin resistance. 94 Further advances in and more widespread use of genomics to study pathogen epidemiology will continue to improve our understanding of how genetic information in pathogens encodes pathology and host specificity. Similar studies outside of Staphylococcus aureus have already shown strong associations between the genotypes of Helicobacter pylori strains and host ethnicity and migratory patterns.
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THE MICROBIOME IN IMMUNE DEVELOPMENT
As a first line of defense against infection, the skin is both a physical and immunologic barrier. Along with the gut, the skin is one of the most heavily immune-surveyed sites in the body. The immune system must not only distinguish between self and other but also perform the more difficult task of distinguishing between beneficial and pathogenic microbes. Because all microbes share similar molecular patterns of lipopolysaccharides and peptidoglycans, it has been a challenge to understand what exactly alerts the immune system to pathogenicity. Evidence now suggests that both skin and gut microbiota play a crucial role in educating and assisting the immune system.
Experiments in germ-free laboratory mice offered the first insights into the crucial role of microbiota to immune development. These mice exhibit defective development of gut-associated lymphoid tissue and mesenteric lymph nodes, reduced epithelial expression of immune molecules, and improper T-cell differentiation. [98] [99] [100] [101] [102] Studies have also shown that disturbances in gut microbiota contribute to diseases of immune dysregulation. [103] [104] [105] [106] [107] Similarly, a recent study has shown that germ-free mice without commensal skin microbes have abnormal cytokine production and cutaneous T-cell populations. 108 These germ-free mice could not mount an appropriate immune response against intradermal Leishmania major infection; however, immunity could be rescued by allowing Staphylococcus epidermidis colonization on the skin of germ-free mice. 108 These results offer tantalizing evidence that, like the gut, the skin has well-developed immune functions at both the epithelial and associated immune tissue levels. Thus, many of the same principles and lines of investigation in the gut microbiome can be applied to the skin microbiome.
Healthy skin barrier consists of both immune surveillance and epidermal keratinocytes, which produce antimicrobial peptides (AMPs) that contribute to innate immunity (Fig 4) . [109] [110] [111] Expression of these AMPs are up-regulated by the presence of Propionibacterium species and other Grampositive bacteria. 112, 113 In addition to AMPs, sebocytes can produce antimicrobial free fatty acids by hydrolyzing sebum triglycerides. This triglyceride hydrolysis is also performed by commensal bacterial flora such as Propionibacterium acnes and Staphylococcus epidermidis. 114, 115 A large number of Gram-positive commensals, including Lactococcus, Streptococcus, and Staphylococcus species, also produce bactericidal factors de novo. 116 Peptides called phenosoluble modulins are produced by Staphylococcus epidermidis and have selective activity against Staphylococcus aureus, group A streptococcus, and Escherichia coli but not other Staphylococcus epidermidis.
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Interestingly, Staphylococcus aureus strains also produce phenosoluble modulins, but these have minimal antimicrobial activity and instead induce lysis of neutrophils whereas Staphylococcus epidermidis phenosoluble modulins have bacteria-killing activity but no effect on neutrophils. 118, 119 Bacterially produced AMPs do not just play a minor role in innate immunity but are abundant on skin and, in nanomolar amounts, can decrease the survival of pathogens on healthy human skin by 2 to 3 log fold. 119, 120 Microbiota not only activate and assist innate immunity but also influence adaptive immunity, although these interactions are more complex and less well understood. Studies in the gut show that the commensal Bacteroides fragilis activates regulatory T cells and stimulates production of anti-inflammatory cytokines, primarily interleukin (IL)-10. 121 Other studies on how gut microbiota might modulate the immune system are reviewed elsewhere. 122, 123 How skin microbiota might influence the innate and adaptive immune system should now be an area of active investigation because so many autoimmune diseasesevitiligo, dermatomyositis, and lupus, to name a fewemanifest on the skin even if they are also systemic.
CANCER IMMUNOLOGY AND THE MICROBIOME
Malignancy has been hypothesized to result from a breakdown in immune surveillance and from mutagenic and proliferative environments, such as chronic inflammation. Because the skin microbiome is important for developing a well-functioning immune system and for modulating inflammation, it may also protect against cancers. In support of this hypothesis, studies have shown that workers, such as farmers and waste incinerator workers, who were exposed heavily to environmental microbiota had lower cancer rates. [124] [125] [126] Cancer and inflammation are linked in multiple ways. Studies have shown that chronic inflammation and tissue injury increases the risk for cancer, as in the relationship between Helicobacter pylori infection and gastric cancer 108, 127 or between burns and squamous cell carcinoma. 128 On the other hand, acute inflammation can activate tumor necrosis factor and IL-12-induced antitumor activity, as in the case of Coley toxin causing sarcoma regression. 129, 130 Commensal skin bacteria have been shown to both reduce inflammation during wound healing 131 and activate innate immunity and inflammatory cytokines. 132 This begs the question, how do commensal bacteria affect skin inflammation and does this contribute to or protect against malignancy?
Evidence has now been provided that certain microbial components actually do have antitumor activity against bladder and colon cancers, at least in part by heightening immunosurveillance. [133] [134] [135] [136] Thus far, there are no published studies on how the microbiome influences genesis and propagation of skin cancers. Global metagenomic assessments of microbiome differences between tumor sites and healthy skin may help explain the different Microbiome and skin immunology. Viruses, bacteria, and fungi ( purple, red, or green dots) cover human skin and its appendages. Keratinocytes produce antimicrobial peptides (AMPs). Sebocytes produce free fatty acids (FFAs). Some commensal microbes also produce AMPs, FFAs, and phenosoluble modulins (PSMs). These molecules all inhibit pathogen colonization. Commensal microbes may also inhibit pathogen growth by competition and crowding on skin surface. Microbiota also interact with immune cells to activate them or modulate their production of pro-and anti-inflammatory cytokines. Backbone skin diagram downloaded and used with permission from Docstoc (www.docstoc.com).
propensities for cancer among individuals and skin habitats despite similar sun exposures and may open the door for new therapeutics.
CONCLUSIONS
Metagenomics has revolutionized our views about the skin microbiome and its interactions with the host epithelial and immune systems. Metagenomics has also yielded many new questions about what factors drive the composition and fluctuations in skin ecosystems, how changes in the microbiome contribute to disease, and how our medical interventions affect the microbiome. For a wide variety of diseases that relate to perturbations in the epidermis or the immune system, such as melanoma, graft-versus-host-disease, and autoimmune diseases, studying the microbiome may provide a new perspective to pathogenic factors and new therapeutic targets. 
